Erratum: Brain iron toxicity: Differential responses of astrocytes, neurons, and endothelial cells (Neurochemical Research 32, 7, (1196-1208) DOI: 10.1007/s11064-007-9290-4);Brain iron toxicity: Differential responses of astrocytes, neurons, and endothelial cells

Neurochemical Research

Volumn 32, Issue 7, 2007, Pages 1196-1208

  Gaasch, Julie A ^a   Lockman, Paul R ^a   Geldenhuys, Werner J ^b   Allen, David D ^b   Van Der Schyf, Cornelis J ^b  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b NORTHEAST OHIO MEDICAL UNIVERSITY   (United States)

Author keywords

Astrocyte; Brain iron toxicity; Endothelial cell; Neurodegeneration; Neuron; Toxic mechanisms

Indexed keywords

ASTROCYTE; BRAIN CELL; BRAIN INJURY; CELL TYPE; CONCENTRATION (PARAMETERS); ENDOTHELIUM CELL; HUMAN; IRON METABOLISM; IRON OVERLOAD; IRON STORAGE; IRON TRANSPORT; NERVE CELL; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; PATHOLOGY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVIEW;

EID: 34249305881     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-007-9488-5     Document Type: Erratum

References (154)

1. Youdim MB, Ben-Shachar D, Yehuda S, Riederer P (1990) The role of iron in the basal ganglion. Adv Neurol 53:155-162
2. Hulet SW, Hess EJ, Debinski W, Arosio P, Bruce K, Powers S, Connor JR (1999) Characterization and distribution of ferritin binding sites in the adult mouse brain. J Neurochem 72:868-874
3. Laskey J, Webb I, Schulman HM, Ponka P (1988) Evidence that transferrin supports cell proliferation by supplying iron for DNA synthesis. Exp Cell Res 176:87-95
4. Connor JR, Pavlick G, Karli D, Menzies SL, Palmer C (1995) A histochemical study of iron-positive cells in the developing rat brain. J Comp Neurol 355:111-123
5. Li D (1998) Effects of iron deficiency on iron distribution and gamma-aminobutyric acid (GABA) metabolism in young rat brain tissues. Hokkaido Igaku Zasshi 73:215-225
6. Hill JM (1985) Iron concentration reduced in ventral pallidum, globus pallidus, and substantia nigra by GABA-transaminase inhibitor, gamma-vinyl GABA. Brain Res 342:18-25
7. Wu LJ, Leenders AG, Cooperman S, Meyron-Holtz E, Smith S, Land W, Tsai RY, Berger UV, Sheng ZH, Rouault TA (2004) Expression of the iron transporter ferroportin in synaptic vesicles and the blood-brain barrier. Brain Res 1001:108-117
8. Papanikolaou G, Pantopoulos K (2005) Iron metabolism and toxicity. Toxicol Appl Pharmacol 202:199-211
9. Moos T, Morgan EH (2004) The metabolism of neuronal iron and its pathogenic role in neurological disease: review. Ann N Y Acad Sci 1012:14-26
10. Gerlach M, Ben-Shachar D, Riederer P, Youdim MBH (1994) Altered Brain Metabolism of Iron as a Cause of Neurodegenerative Diseases? J Neurochem 63:793-807
11. Weaver J, Pollack S, Zhan H (1989) Low molecular weight iron from guinea pig reticulocytes isolated by Sephadex G-25 chromatography. Eur J Haematol 43:321-327
12. Mulligan M, Althaus B, Linder M (1986) Non-ferritin, non-heme iron pools in rat tissues. Int J Biochem 18:791-798
13. Bishop GM, Robinson SR (2001) Quantitative analysis of cell death and ferritin expression in response to cortical iron: implications for hypoxia-ischemia and stroke. Brain Res 907:175-187
14. Triggs WJ, Willmore LJ (1984) In vivo lipid peroxidation in rat brain following intracortical Fe2+ injection. J Neurochem 42:976-980
15. Schenck JF, Zimmerman EA (2004) High-field magnetic resonance imaging of brain iron: birth of a biomarker? NMR Biomed 17:433-445
16. Hallgren B, Sourander P (1958) The effect of age on the non-haemin iron in the human brain. J Neurochem 3:41-51
17. Gotz ME, Double K, Gerlach M, Youdim MB, Riederer P (2004) The relevance of iron in the pathogenesis of Parkinson's disease. Ann N Y Acad Sci 1012:193-208
18. Beal MF (1998) Mitochondrial dysfunction in neurodegenerative diseases. Biochim Biophys Acta 1366:211-223
19. Aisen P (1992) Entry of iron into cells: a new role for the transferrin receptor in modulating iron release from transferrin. Ann Neurol 32:S62-S68
20. Aisen P, Wessling-Resnick M, Leibold EA (1999) Iron metabolism. Curr Opin Chem Biol 3:200-206
21. Rolfs A, Hediger MA (1999) Metal ion transporters in mammals: structure, function and pathological implications. J Physiol 518(Pt 1):1-12
22. Crichton RR, Wilmet S, Legssyer R, Ward RJ (2002) Molecular and cellular mechanisms of iron homeostasis and toxicity in mammalian cells. J Inorg Biochem 91:9-18
23. Breuer W, Epsztejn S, Cabantchik ZI (1996) Dynamics of the cytosolic chelatable iron pool of K562 cells. FEBS Lett 382:304-308
24. Zecca L, Youdim MB, Riederer P, Connor JR, Crichton RR (2004) Iron, brain ageing and neurodegenerative disorders. Nat Rev Neurosci 5:863-873
25. Goswami T, Rolfs A, Hediger MA (2002) Iron transport: emerging roles in health and disease. Biochem Cell Biol 80:679-689
26. Banks WA, Kastin AJ, Fasold MB, Barrera CM, Augereau G (1988) Studies of the slow bidirectional transport of iron and transferrin across the blood-brain barrier. Brain Res Bull 21:881-885
27. Fishman JB, Rubin JB, Handrahan JV, Connor JR, Fine RE (1987) Receptor-mediated transcytosis of transferrin across the blood-brain barrier. J Neurosci Res 18:299-304
28. Moroo I, Ujiie M, Walker BL, Tiong JW, Vitalis TZ, Karkan D, Gabathuler R, Moise AR, Jefferies WA (2003) Identification of a novel route of iron transcytosis across the mammalian blood-brain barrier. Microcirculation 10:457-462
29. Bartlett W, Li X, Connor J (1991) Expression of transferrin mRNA in the CNS of normal and jimpy mice. J Neurochem 57:318-322
30. Crowe A, Morgan EH (1992) Iron and transferrin uptake by brain and cerebrospinal fluid in the rat. Brain Res 592:8-16
31. Jefferies WA, Brandon MR, Hunt SV, Williams AF, Gatter KC, Mason DY (1984) Transferrin receptor on endothelium of brain capillaries. Nature 312:162-163
32. Wagner KR, Sharp FR, Ardizzone TD, Lu A, Clark JF (2003) Heme and iron metabolism: role in cerebral hemorrhage. J Cerebr Blood Flow Metab 23:629-652
33. Moos T (1996) Immunohistochemical localization of intraneuronal transferrin receptor immunoreactivity in the adult mouse central nervous system. J Comp Neurol 375:675-692
34. Ueda F, Raja KB, Simpson RJ, Trowbridge IS, Bradbury MW (1993) Rate of 59Fe uptake into brain and cerebrospinal fluid and the influence thereon of antibodies against the transferrin receptor. J Neurochem 60:106-113
35. Gutteridge JM (1992) Ferrous ions detected in cerebrospinal fluid by using bleomycin and DNA damage. Clin Sci (Lond) 82:315-320
36. Qian ZM, Shen X (2001) Brain iron transport and neurodegeneration. Trends Mol Med 7:103-108
37. Lash A, Saleem A (1995) Iron metabolism and its regulation. A review Ann Clin Lab Sci 25:20-30
38. Burdo JR, Connor JR (2003) Brain iron uptake and homeostatic mechanisms: an overview. Biometals 16:63-75
39. Seligman PA, Schleicher RB (1999) Comparison of methods used to measure serum iron in the presence of iron gluconate or iron dextran. Clin Chem 45:898-901
40. Moos T, Morgan EH (1998) Evidence for low molecular weight, non-transferrin-bound iron in rat brain and cerebrospinal fluid. J Neurosci Res 54:486-494
41. Bradbury MW (1997) Transport of iron in the blood-brain-cerebrospinal fluid system. J Neurochem 69:443-454
42. Selim MH, Ratan RR (2004) The role of iron neurotoxicity in ischemic stroke. Ageing Res Rev 3:345-353
43. Bleijenberg BG, Eijk van HG, Leijnse B (1971) The determination of non-heme iron and transferrin in cerebrospinal fluid. Clin Chim Acta 31:277-281
44. Del Principe D, Menichelli A, Colistra C (1989) The ceruloplasmin and transferrin system in cerebrospinal fluid of acute leukemia patients. Acta Paediatr Scand 78:327-328
45. Ji B, Maeda J, Higuchi M, Inoue K, Akita H, Harashima H, Suhara T (2006) Pharmacokinetics and brain uptake of lactoferrin in rats. Life Sci 78:851-855
46. Sawyer ST, Krantz SB (1986) Transferrin receptor number, synthesis, and endocytosis during erythropoietin-induced maturation of Friend virus-infected erythroid cells. J Biol Chem 261:9187-9195
47. Lipschitz DA, Cook JD, Finch CA (1974) A clinical evaluation of serum ferritin as an index of iron stores. N Engl J Med 290:1213-1216
48. Haerer AF (1971) Citrate and alpha-ketoglutarate in cerebrospinal fluid and blood. Neurology 21:1059-1065
49. Spector R, Lorenzo AV (1973) Ascorbic acid homeostasis in the central nervous system. Am J Physiol 225:757-763
50. Mukhopadhyay CK, Attieh ZK, Fox PL (1998) Role of ceruloplasmin in cellular iron uptake. Science 279:714-717
51. Fillebeen C, Descamps L, Dehouck MP, Fenart L, Benaissa M, Spik G, Cecchelli R, Pierce A (1999) Receptor-mediated transcytosis of lactoferrin through the blood-brain barrier. J Biol Chem 274:7011-7017
52. Terent A, Hallgren R, Venge P, Bergstrom K (1981) Lactoferrin, lysozyme, and beta 2-microglobulin in cerebrospinal fluid. Elevated levels in patients with acute cerebrovascular lesions as indices of inflammation. Stroke 12:40-46
53. Morris C, Candy J, Keith A, Oakley A, Taylor G, Pullen R, Bloxham C, Gocht A, Edwardson J (1992) Brain iron homeostasis. J Inorg Biochem 47:257-265
54. Koeppen AH (1995) The history of iron in the brain. J Neurol Sci 134(Suppl):1-9
55. Wixom RL, Prutkin L, Munro HN (1980) Hemosiderin: nature, formation, and significance. Int Rev Exp Pathol 22:193-225
56. Theil EC (1987) Ferritin: structure, gene regulation, and cellular function in animals, plants, and microorganisms. Annu Rev Biochem 56:289-315
57. Testa U (2002) Ferritin., in Proteins of Iron Metabolism, CRC Press, Boca Raton. pp449-538
58. Iancu TC (1992) Ferritin and hemosiderin in pathological tissues. Electron Microsc Rev 5:209-229
59. Nunez-Millacura C, Tapia V, Munoz P, Maccioni RB, Nunez MT (2002) An oxidative stress-mediated positive-feedback iron uptake loop in neuronal cells. J Neurochem 82:240-248
60. Jeong SY, David S (2003) Glycosylphosphatidylinositol-anchored ceruloplasmin is required for iron efflux from cells in the central nervous system. J Biol Chem 278:27144-27148
61. Aguirre P, Mena N, Tapia V, Arredondo M, and Nunez, MT (2005) Iron homeostasis in neuronal cells: a role for IREG1. BMC Neurosci. 6:article 3
62. Baldwin DA, Jenny ER, Aisen P (1984) The effect of human serum transferrin and milk lactoferrin on hydroxyl radical formation from superoxide and hydrogen peroxide. J Biol Chem 259:13391-13394
63. Connor JR, Menzies SL, Burdo JR, Boyer PJ (2001) Iron and iron management proteins in neurobiology. Pediatr Neurol 25:118-129
64. Siesjo BK, Agardh CD, Bengtsson F (1989) Free radicals and brain damage. Cerebrovasc Brain Metab Rev 1:165-211
65. Baader SL, Bruchelt G, Carmine TC, Lode HN, Rieth AG, Niethammer D (1994) Ascorbic-acid-mediated iron release from cellular ferritin and its relation to the formation of DNA strand breaks in neuroblastoma cells. J Cancer Res Clin Oncol 120:415-421
66. Ying W, Han SK, Miller JW, Swanson RA (1999) Acidosis potentiates oxidative neuronal death by multiple mechanisms. J Neurochem 73:1549-1556
67. Breuer W, Greenberg E, Cabantchik ZI (1997) Newly delivered transferrin iron and oxidative cell injury. FEBS Lett 403:213-219
68. Cable EE, Connor JR, Isom HC (1998) Accumulation of iron by primary rat hepatocytes in long-term culture: changes in nuclear shape mediated by non-transferrin-bound forms of iron. Am J Pathol 152:781-792
69. Rauhala P, Chiueh CC (2000) Effects of atypical antioxidative agents, S-nitrosoglutathione and manganese, on brain lipid peroxidation induced by iron leaking from tissue disruption. Ann N Y Acad Sci 899:238-254
70. Halliwell BG, Gutteridge JMC (eds) (1998) Free Radicals in Biology and Medicine, 3rd Ed. Oxford University Press, Oxford, p 729
71. Ward RJ, Kuhn LC, Kaldy P, Florence A, Peters TJ, Crichton RR (1994) Control of cellular iron homeostasis by iron-responsive elements In vivo. Eur J Biochem 220:927-931
72. Alexandrov PN, Zhao Y, Pogue AI, Tarr MA, Kruck TP, Percy ME, Cui JG, Lukiw WJ (2005) Synergistic effects of iron and aluminum on stress-related gene expression in primary human neural cells. J Alz Dis 8:117-127
73. Varani J, Fligiel SE, Till GO, Kunkel RG, Ryan US, Ward PA (1985) Pulmonary endothelial cell killing by human neutrophils. Possible involvement of hydroxyl radical Lab Invest 53:656-663
74. Smith C, Mitchinson MJ, Aruoma OI, Halliwell B (1992) Stimulation of lipid peroxidation and hydroxyl-radical generation by the contents of human atherosclerotic lesions. Biochem J 286(Pt 3):901-905
75. Balla G, Jacob HS, Balla J, Rosenberg M, Nath K, Apple F, Eaton JW, Vercellotti GM (1992) Ferritin: a cytoprotective antioxidant strategem of endothelium. J Biol Chem 267:18148-18153
76. Halliwell B (2006) Oxidative stress and neurodegeneration: where are we now? J Neurochem 97:1634-1658
77. Aracena P, Tang W, Hamilton SL, Hidalgo C (2005) Effects of S-glutathionylation and S-nitrosylation on calmodulin binding to triads and FKBP12 binding to type 1 calcium release channels. Antioxid Redox Signal 7:870-881
78. Oubidar M, Marie C, Mossiat C, Bralet J (1996) Effects of increasing intracellular reactive iron level on cardiac function and oxidative injury in the isolated rat heart. J Mol Cell Cardiol 28:1769-1776
79. Zhang Z, Wei T, Hou J, Li G, Yu S, Xin W (2003) Iron-induced oxidative damage and apoptosis in cerebellar granule cells: attenuation by tetramethylpyrazine and ferulic acid. Eur J Pharmacol 467:41-47
80. Willmore LJ, Rubin JJ (1982) Formation of malonaldehyde and focal brain edema induced by subpial injection of FeCl2 into rat isocortex. Brain Res 246:113-119
81. Zhang Y, Tatsuno T, Carney JM, Mattson MP (1993) Basic FGF, NGF, and IGFs protect hippocampal and cortical neurons against iron-induced degeneration. J Cereb Blood Flow Metab 13:378-388
82. Link G, Saada A, Pinson A, Konijn AM, Hershko C (1998) Mitochondrial respiratory enzymes are a major target of iron toxicity in rat heart cells. J Lab Clin Med 131:466-474
83. Calabrese V, Lodi R, Tonon C, D'Agata V, Sapienza M, Scapagnini G, Mangiameli A, Pennisi G, Stella AM, Butterfield DA (2005) Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia. J Neurol Sci 233:145-162
84. Shamoto-Nagai M, Maruyama W, Yi H, Akao Y, Tribl F, Gerlach M, Osawa T, Riederer P, Naoi M (2006) Neuromelanin induces oxidative stress in mitochondria through release of iron: mechanism behind the inhibition of 26S proteasome. J Neural Transm 113:633-644
85. Robb SJ, Robb-Gaspers LD, Scaduto RC Jr, Thomas AP, Connor JR (1999) Influence of calcium and iron on cell death and mitochondrial function in oxidatively stressed astrocytes. J Neurosci Res 55:674-686
86. Smith SR, Cooperman S, Lavaute T, Tresser N, Ghosh M, Meyron-Holtz E, Land W, Ollivierre H, Jortner B, Switzer R 3rd, Messing A, Rouault TA (2004) Severity of neurodegeneration correlates with compromise of iron metabolism in mice with iron regulatory protein deficiencies. Ann N Y Acad Sci 1012:65-83
87. Berg D, Gerlach M, Youdim MBH, Double KL, Zecca L, Riederer P, Becker G (2001) Brain iron pathways and their relevance to Parkinson's disease. J Neurochem 79:225-236
88. Yamamoto A, Shin R-W, Hasegawa K, Naiki H, Sato H, Yoshimasu F, Kitamoto T (2003) Iron (III) induces aggregation of hyperphosphorylated tau and its reduction to iron (II) reverses the aggregation: implications in the formation of neurofibrillary tangles of Alzheimer's disease. J Neurochem 86:1568-1568
89. Bishop GM, Robinson SR, Liu Q, Perry G, Atwood CS, Smith MA (2002) Iron: a pathological mediator of Alzheimer disease? Dev Neurosci 24:184-187
90. Turner CP, Bergeron M, Matz P, Zegna A, Noble LJ, Panter SS, Sharp FR (1998) Heme oxygenase-1 is induced in glia throughout brain by subarachnoid hemoglobin. J Cereb Blood Flow Metab 18:257-273
91. Vayenas DV, Repanti M, Vassilopoulos A, Papanastasiou DA (1998) Influence of iron overload on manganese, zinc, and copper concentration in rat tissues In vivo: study of liver, spleen, and brain. Int J Clin Lab Res 28:183-186
92. Castellani RJ, Smith MA, Nunomura A, Harris PL, Perry G (1999) Is increased redox-active iron in Alzheimer disease a failure of the copper-binding protein ceruloplasmin? Free Radic Biol Med 26:1508-1512
93. Thompson KJ, Shoham S, Connor JR (2001) Iron and neurodegenerative disorders. Brain Res Bull 55:155-164
94. Smith MA, Hirai K, Hsiao K, Pappolla MA, Harris PL, Siedlak SL, Tabaton M, Perry G (1998) Amyloid-beta deposition in Alzheimer transgenic mice is associated with oxidative stress. J Neurochem 70:2212-2215
95. Mantyh PW, Ghilardi JR, Rogers S, DeMaster E, Allen CJ, Stimson ER, Maggio JE (1993) Aluminum, iron, and zinc ions promote aggregation of physiological concentrations of beta-amyloid peptide. J Neurochem 61:1171-1174
96. Rogers JT, Leiter LM, McPhee J, Cahill CM, Zhan SS, Potter H, Nilsson LN (1999) Translation of the alzheimer amyloid precursor protein mRNA is up-regulated by interleukin-1 through 5'-untranslated region sequences. J Biol Chem 274:6421-6431
97. Connor JR, Menzies SL, St Martin SM, Mufson EJ (1992) A histochemical study of iron, transferrin, and ferritin in Alzheimer's diseased brains. J Neurosci Res 31:75-83
98. Sayre LM, Perry G, Atwood CS, Smith MA (2000) The role of metals in neurodegenerative diseases. Cell Mol Biol (Noisy-le-grand) 46:731-741
99. Ruprecht-Dorfler P, Berg D, Tucha O, Benz P, Meier-Meitinger M, Alders GL, Lange KW, Becker G (2003) Echogenicity of the substantia nigra in relatives of patients with sporadic Parkinson's disease. Neuroimage 18:416-422
100. Griffiths PD, Dobson BR, Jones GR, Clarke DT (1999) Iron in the basal ganglia in Parkinson's disease. An in vitro study using extended X-ray absorption fine structure and cryo-electron microscopy. Brain 122(Pt 4):667-673
101. Mohanakumar KP, de Bartolomeis A, Wu RM, Yeh KJ, Sternberger LM, Peng SY, Murphy DL, Chiueh CC (1994) Ferrous-citrate complex and nigral degeneration: evidence for free-radical formation and lipid peroxidation. Ann N Y Acad Sci 738:392-399
102. Sengstock GJ, Olanow CW, Menzies RA, Dunn AJ, Arendash GW (1993) Infusion of iron into the rat substantia nigra: nigral pathology and dose-dependent loss of striatal dopaminergic markers. J Neurosci Res 35:67-82
103. Sziraki I, Mohanakumar KP, Rauhala P, Kim HG, Yeh KJ, Chiueh CC (1998) Manganese: a transition metal protects nigrostriatal neurons from oxidative stress in the iron-induced animal model of parkinsonism. Neuroscience 85:1101-1111
104. Sofic E, Riederer P, Heinsen H, Beckmann H, Reynolds GP, Hebenstreit G, Youdim MB (1988) Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain. J Neural Transm 74:199-205
105. Moos T, Morgan EH (2000) Transferrin and transferrin receptor function in brain barrier systems. Cell Mol Neurobiol 20:77-95
106. Becker G, Seufert J, Bogdahn U, Reichmann H, Reiners K (1995) Degeneration of substantia nigra in chronic Parkinson's disease visualized by transcranial color-coded real-time sonography. Neurology 45:182-184
107. Berg D, Hochstrasser H, Schweitzer KJ, Riess O (2006) Disturbance of iron metabolism in Parkinson's disease - ultrasonography as a biomarker. Neurotox Res 9:1-13
108. Faucheux BA, Martin ME, Beaumont C, Hauw JJ, Agid Y, Hirsch EC (2003) Neuromelanin associated redox-active iron is increased in the substantia nigra of patients with Parkinson's disease. J Neurochem 86:1142-1148
109. Jurma OP, Hom DG, Andersen JK (1997) Decreased glutathione results in calcium-mediated cell death in PC12. Free Radic Biol Med 23:1055-1066
110. Levenson CW (2005) Trace metal regulation of neuronal apoptosis: from genes to behavior. Physiol Behav 86:399-406
111. Takeda A, Takatsuka K, Connor JR, Oku N (2002) Abnormal iron delivery to the bone marrow in neonatal hypotransferrinemic mice. Biometals 15:33-36
112. Borie C, Gasparini F, Verpillat P, Bonnet AM, Agid Y, Hetet G, Brice A, Durr A, Grandchamp B (2002) Association study between iron-related genes polymorphisms and Parkinson's disease. J Neurol 249:801-804
113. Moalem S, Percy ME, Andrews DF, Kruck TP, Wong S, Dalton AJ, Mehta P, Fedor B, Warren AC (2000) Are hereditary hemochromatosis mutations involved in Alzheimer disease? Am J Med Genet 93:58-66
114. Levy YS, Streifler JY, Panet H, Melamed E, Offen D (2002) Hemin-induced apoptosis in PC12 and neuroblastoma cells: implications for local neuronal death associated with intracerebral hemorrhage. Neurotox Res 4:609-616
115. Kajikawa H, Ohta T, Yoshikawa Y, Funatsu N, Yamamoto M, Someda K (1979) Cerebral vasospasm and hemoglobins-clinical and experimental studies. Neurol Med Chir (Tokyo) 19:61-71
116. Regan RF, Panter SS (1993) Neurotoxicity of hemoglobin in cortical cell culture. Neurosci Lett 153:219-222
117. Maines MD (1997) The heme oxygenase system: a regulator of second messenger gases. Annu Rev Pharmacol Toxicol 37:517-554
118. Wan S, Hua Y, Keep RF, Hoff JT, Xi G (2006) Deferoxamine reduces CSF free iron levels following intracerebral hemorrhage. Acta Neurochir Suppl 96:199-202
119. Wu J, Hua Y, Keep RF, Nakamura T, Hoff JT, Xi G (2003) Iron and iron-handling proteins in the brain after intracerebral hemorrhage. Stroke 34:2964-2969
120. Hua Y, Nakamura T, Keep RF, Wu J, Schallert T, Hoff JT, Xi G (2006) Long-term effects of experimental intracerebral hemorrhage: the role of iron. J Neurosurg 104:305-312
121. Koeppen AH, Dickson AC, McEvoy JA (1995) The cellular reactions to experimental intracerebral hemorrhage. J Neurol Sci 134(Suppl):102-112
122. Xue M, Del Bigio MR (2000) Intracerebral injection of autologous whole blood in rats: time course of inflammation and cell death. Neurosci Lett 283:230-232
123. Kress GJ, Dineley KE, Reynolds IJ (2002) The relationship between intracellular free iron and cell injury in cultured neurons, astrocytes, and oligodendrocytes. J Neurosci 22:5848-5855
124. Ke ZJ, Gibson GE (2004) Selective response of various brain cell types during neurodegeneration induced by mild impairment of oxidative metabolism. Neurochem Int 45:361-369
125. Ferguson M, Dalve-Endres AM, McRee RC, Langlais PJ (1999) Increased mast cell degranulation within thalamus in early pre-lesion stages of an experimental model of Wernicke's encephalopathy. J Neuropathol Exp Neurol 58:773-783
126. Norenberg MD (1996) Reactive Astrocytosis. In: Aschner M, Kimelberg HK (eds) The Role of Glia in Neurotoxicity. CRC Press, Boca Raton, pp 93-100
127. Abbott NJ, Ronnback L, Hansson E (2006) Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 7:41-53
128. Landis DM (1994) The early reactions of non-neuronal cells to brain injury. Annu Rev Neurosci 17:133-151
129. Dehouck MP, Meresse S, Delorme P, Fruchart JC, Cecchelli R (1990) An easier, reproducible, and mass-production method to study the blood-brain barrier in vitro. J Neurochem 54:1798-1801
130. Schinkel AH (1999) P-Glycoprotein, a gatekeeper in the blood-brain barrier. Adv Drug Deliv Rev 36:179-194
131. Ullian EM, Christopherson KS, Barres BA (2004) Role for glia in synaptogenesis. Glia 47:209-216
132. Takano T, Tian GF, Peng W, Lou N, Libionka W, Han X, Nedergaard M (2006) Astrocyte-mediated control of cerebral blood flow. Nat Neurosci 9:260-267
133. Makar TK, Nedergaard M, Preuss A, Gelbard AS, Perumal AS, Cooper AJ (1994) Vitamin E, ascorbate, glutathione, glutathione disulfide, and enzymes of glutathione metabolism in cultures of chick astrocytes and neurons: evidence that astrocytes play an important role in antioxidative processes in the brain. J Neurochem 62:45-53
134. Aschner M (1996) The functional significance of brain metallothioneins. Faseb J 10:1129-1136
135. Raps SP, Lai JC, Hertz L, Cooper AJ (1989) Glutathione is present in high concentrations in cultured astrocytes but not in cultured neurons. Brain Res 493:398-401
136. Oide T, Yoshida K, Kaneko K, Ohta M, Arima K (2006) Iron overload and antioxidative role of perivascular astrocytes in aceruloplasminemia. Neuropathol Appl Neurobiol 32:170-176
137. Sawada J, Kikuchi Y, Shibutani M, Mitsumori K, Inoue K, Kasahara T (1994) Induction of metallothionein in astrocytes by cytokines and heavy metals. Biol Signals 3:157-168
138. Wang XS, Ong WY, Connor JR (2001) A light and electron microscopic study of the iron transporter protein DMT-1 in the monkey cerebral neocortex and hippocampus. J Neurocytol 30:353-360
139. Hoepken HH, Korten T, Robinson SR, Dringen R (2004) Iron accumulation, iron-mediated toxicity and altered levels of ferritin and transferrin receptor in cultured astrocytes during incubation with ferric ammonium citrate. J Neurochem 88:1194-1202
140. Regan RF, Kumar N, Gao F, Guo Y (2002) Ferritin induction protects cortical astrocytes from heme-mediated oxidative injury. Neuroscience 113:985-994
141. Stohs SJ, Bagchi D (1995) Oxidative mechanisms in the toxicity of metal ions. Free Radic Biol Med 18:321-336
142. Erikson KM, Aschner M (2006) Increased manganese uptake by primary astrocyte cultures with altered iron status is mediated primarily by divalent metal transporter. Neurotoxicol 27:125-130
143. Iwata-Ichikawa E, Kondo Y, Miyazaki I, Asanuma M, Ogawa N (1999) Glial cells protect neurons against oxidative stress via transcriptional up-regulation of the glutathione synthesis. J Neurochem 72:2334-2344
144. Schroeter ML, Mertsch K, Giese H, Muller S, Sporbert A, Hickel B, Blasig IE (1999) Astrocytes enhance radical defence in capillary endothelial cells constituting the blood-brain barrier. FEBS Lett 449:241-244
145. Wagner KR, Broderick JP (2001) Hemorrhagic stroke: pathophysiological mechanisms and neuroprotective treatments. In: Wagner KR, Bryan DW, Hall CL, Courten-Myers de GM, Broderick JP (eds) Neuroprotection. Prominent Press, Scottsdale, AZ, pp 471-508
146. Williams K, Wilson MA, Bressler J (2000) Regulation and developmental expression of the divalent metal-ion transporter in the rat brain. Cell Mol Biol (Noisy-le-grand) 46:563-571
147. Grady MS, Charleston JS, Maris D, Witgen BM, Lifshitz J (2003) Neuronal and glial cell number in the hippocampus after experimental traumatic brain injury: analysis by stereological estimation. J Neurotrauma 20:929-941
148. Hill SJ, Barbarese E, McIntosh TK (1996) Regional heterogeneity in the response of astrocytes following traumatic brain injury in the adult rat. J Neuropathol Exp Neurol 55:1221-1229
149. Zhao X, Ahram A, Berman RF, Muizelaar JP, Lyeth BG (2003) Early loss of astrocytes after experimental traumatic brain injury. Glia 44:140-152
150. Brahmachari S, Fung YK, Pahan K (2006) Induction of glial fibrillary acidic protein expression in astrocytes by nitric oxide. J Neurosci 26:4930-4939
151. Tani M, Glabinski AR, Tuohy VK, Stoler MH, Estes ML, Ransohoff RM (1996) In situ hybridization analysis of glial fibrillary acidic protein mRNA reveals evidence of biphasic astrocyte activation during acute experimental autoimmune encephalomyelitis. Am J Pathol 148:889-896
152. Van der Schyf CJ, Geldenhuys WJ, Youdim MB (2006) Multifunctional neuroprotective drugs for the treatment of cognitive and movement impairment disorders, including Alzheimer's and Parkinson's diseases. Drugs Fut 31:447-460
153. Van der Schyf CJ, Gal S, Geldenhuys WJ, Youdim MB (2006) Multifunctional neuroprotective drugs targeting monoamine oxidase inhibition, iron chelation, adenosine receptors, and cholinergic and glutamatergic action for neurodegenerative diseases. Expert Opin Investig Drugs 15:873-886
154. Van der Schyf CJ, Geldenhuys WJ, Youdim MB (2006) Multifunctional drugs with different CNS targets for neuropsychiatric disorders. J Neurochem 99:1033-1048